The CARA chart settings shown below allow you to select time intervals of 1 min, 30 mins, an hour or by day - week - month. There is also the ability to change the CARA chart style to candles, hollow candles, bars, lines or add various indicators. You can even add a symbol and compare history.
The CARA stock resources shown below were gathered to cut back on time by allowing you to visit multiple sites at once. For your convenience each link clicked will open in a window. In addition to the individual links there is a button at the bottom that will allow you to open all the links at the same time. Note opening all links at once may not work with all browsers. Some browsers block multiple windows, to resolve this please allow that site to use pop-ups.
|View CARA Detailed Price Forecast - CNN Money||View CARA Detailed Summary - Google Finance|
|View CARA Detailed Summary - Yahoo! Finance||View CARA Stock Research & Analysis - Zacks.com|
|View CARA Trends & Analysis - Trade-Ideas||View CARA Major Holders - Barrons|
|View CARA Call Transcripts - NASDAQ||View CARA Breaking News & Analysis - Seeking Alpha|
|View CARA Annual Report - CompanySpotlight.com||View CARA OTC Short Report - OTCShortReport.com|
|View CARA Fundamentals - TradeKing||View CARA SEC Filings - Bar Chart|
|View Historical Prices for CARA - The WSJ||View Performance/Total Return for CARA - Morningstar|
|View the Analyst Estimates for CARA - MarketWatch||View the Earnings History for CARA - CNBC|
|View the CARA Earnings - StockMarketWatch||View CARA Buy or Sell Recommendations - MacroAxis|
|View the CARA Bullish Patterns - American Bulls||View CARA Short Pain Metrics - ShortPainBot.com|
|View CARA Stock Mentions - StockTwits||View CARA Stock Mentions - PennyStockTweets|
|View CARA Stock Mentions - Twitter||View CARA Investment Forum News - Investor Hub|
|View CARA Stock Mentions - Yahoo! Message Board||View CARA Stock Mentions - Seeking Alpha|
|View Insider Transactions for CARA - SECform4.com||View Insider Transactions for CARA - Insider Cow|
|View CARA Major Holdings Summary - CNBC||View Insider Disclosure for CARA - OTC Markets|
|View Insider Transactions for CARA - Yahoo! Finance||View Institutional Holdings for CARA - NASDAQ|
|View CARA Stock Insight & Charts - FinViz.com||View CARA Investment Charts - StockCharts.com|
|View CARA Stock Overview & Charts - BarChart||View CARA User Generated Charts - Trading View|
BridgeBio (BBIO) Begins Dosing with Gene Therapy in CAH Study
Posted on Friday January 28, 2022
BridgeBio (BBIO) doses the first patient in a phase I/II study evaluating its investigational gene therapy candidate, BBP-631, for treating classic congenital adrenal hyperplasia.
ALX Oncology's (ALXO) Evorpacept Gets Orphan Drug Tag for GC
Posted on Friday January 28, 2022
The FDA bestows an Orphan Drug status to ALX Oncology's (ALXO) lead candidate, evorpacept, for treating gastric cancer and gastroesophageal junction cancer.
Horizon (HZNP) Begins Enrollment in Rare Lung Disease Study
Posted on Tuesday January 25, 2022
Horizon (HZNP) enrolls the first patient in a phase IIb study evaluating HZN-825 for the treatment of idiopathic pulmonary fibrosis.
Cara Therapeutics Announces Difelikefalin (KORSUVA™) Injection Achieves Positive Topline Results in Phase 3 Clinical Study in Japan for the Treatment of Pruritus in Hemodialysis Patients
Posted on Monday January 10, 2022
Study met both primary and secondary endpointsSTAMFORD, Conn., Jan. 10, 2022 (GLOBE NEWSWIRE) -- Cara Therapeutics, Inc. (Nasdaq: CARA), an early commercial-stage biopharmaceutical company leading a new treatment paradigm to improve the lives of patients suffering from pruritus, today announced that its licensing partner Maruishi Pharmaceutical Co., Ltd., and its sublicensee Kissei Pharmaceutical Co., Ltd., confirmed the primary endpoint was achieved in a Japanese Phase 3 clinical study (double-